packageRasburicase

rasburicase

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Rasburicase is used to treat hyperuricemia, particularly as a detoxifying agent during antineoplastic treatment. It is authorised in the European Union and is mainly used in hospital settings for chemotherapy-related hyperuricemia.

Summary written by glm-5.3-flash from Wikidata Q3088229 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:rasburicase
ATC codes:V03AF07
DrugBank:DB00049
Wikidata:Q3088229
molar mass:34109.5 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown